首页 › 胰腺癌 › 俄亥俄州 › Cincinnati
Cincinnati OH 胰腺癌临床试验
11项针对 胰腺癌的研究正在 Cincinnati及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
招募中3 期
- University of Cincinnati Cancer Center, Cincinnati
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
招募中3 期
- Saint Elizabeth Medical Center, Inc. DBA St. Elizabeth Health Care, Edgewood · 距离 8 英里
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
招募中1/2 期
- University of Cincinnati Medical Center, Cincinnati
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
招募中观察性研究
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
招募中3 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 距离 15 英里
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- The Christ Hospital, Cincinnati
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
招募中3 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- 以及另外 3 项
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
招募中1/2 期
- Christ Hospital Cancer Center, Cincinnati
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
招募中2 期
- Ohio State University-Telemedicine, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Cincinnati
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
招募中1/2 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
其他城市的 胰腺癌试验
- Houston, TX61 项研究
- New York City, NY60 项研究
- Boston, MA43 项研究
- Nashville, TN39 项研究
- Los Angeles, CA35 项研究
- St. Louis, MO33 项研究
- Arlington, VA33 项研究
- Baltimore, MD31 项研究
- San Antonio, TX31 项研究
- Philadelphia, PA26 项研究
- Tampa, FL26 项研究
- Durham, NC24 项研究
Cincinnati的其他研究
- 非小细胞肺癌35 项研究
- 癌症(所有类型)27 项研究
- 乳腺癌25 项研究
- 心力衰竭24 项研究
- 结直肠癌21 项研究
- 转移性癌症21 项研究
- 急性髓系白血病20 项研究
- 卵巢癌19 项研究
- 肥胖症19 项研究
- 肺癌19 项研究
- 前列腺癌18 项研究
- 黑色素瘤17 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。